The global zoonotic disease treatment market is expected to grow at a progressive growth rate during the forecast period. Increase in the global population and rise in migration of people to the urban areas is expected to increase the zoonotic disease cases in the coming years. Overcrowding coupled with poor sanitation make urban areas vulnerable and conductive to zoonotic disease transmission. Moreover, the greater consumption of animal protein is likely to the increase in zoonotic disease transmission which in turn is expected to propel the growth of the zoonotic disease treatment market.
Zoonotic diseases are the rare disease that is usually spread from animals to humans and from humans to animals. These diseases can be transmitted by direct contact through air and any object bearing such disease. Zoonotoic diseases are also transmitted by insects that harbor the viruses such as bacteria, viruses, parasites and fungi. The greatest challenge is to detect zoonotic disease symptoms in animals. At times zoonotic disease affected animal may appear healthy and when consumed make people sick. The sickness may range from mild sickness to the death in certain cases. Strict government regulation for the detection and treatment of such animals propels the growth of the zoonotic disease treatment market.
Zoonotic disease treatment market is expanding due to the migration of people in urban areas. The population explosion in the urban area leads to the improper sanitation, as a result these areas become the breeding ground of such diseases. Nevertheless, the increasing awareness about animal health is one of the factors driving the growth of the zoonotic disease treatment market. Subsequently, the rising number of preventive vaccines augments the growth of the zoonotoic disease treatment market in the years to come. However, the high capital required for research and development, and the high prices of the drugs hamper the growth of the zoonotic disease treatment market.
The global zoonotic disease treatment market is segmented by types into causing agents, drug classes and end-users. By type, the zoonotic disease treatment market is segmented into viral hepatitis, rabies, relapsing fever, tuberculosis and malaria among others. Zoonotic disease treatment market is segmented on the basis of causative agents as bacteria, nematode, virus, rodents, and ticks among others. By drug class, zoonotic disease treatment market includes antibacterial medications, antifungal medications, and antibiotics among others. End-users segmentation includes hospitals and clinics.
Geographically, North America is expected to dominate the global zoonotic disease treatment market during the forecast period. The innovative healthcare set-ups and improved healthcare expenditure is the prime reason driving the growth in the region. Poor sanitation services and the lack of safe drinking water in several nations of Asia-Pacific region and Rest of the World (Middle East & Africa) are expected to augment the growth of the zoonotic disease treatment market in the region.
The key players dealing in the global zoonotic disease treatment market include Sanofi, Novartis AG, Pfizer Inc., Johnson & Johnson, GlaxoSmithKline, plc F.Hoffmann-La Roche Ltd., AstraZeneca, BioCryst Pharmaceuticals, Cadila Healthcare, and Merial among others.
Global Zoonotic Disease Treatment Market outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023